166 related articles for article (PubMed ID: 7325582)
1. Therapeutic, clinical and histological factors related to the survival of patients with advanced ovarian carcinoma.
Kauppila A; Kivinen S; Mäkilä UM; Järvinen PA
Ann Chir Gynaecol; 1981; 70(3):91-5. PubMed ID: 7325582
[TBL] [Abstract][Full Text] [Related]
2. Results of treatment of primary ovarian carcinoma.
Saarikoski S; Selander K; Kauppila O; Raitala R; Pystynen P
Ann Chir Gynaecol; 1982; 71(3):156-60. PubMed ID: 7114781
[TBL] [Abstract][Full Text] [Related]
3. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative radiotherapy of epithelial ovarian cancers].
Kucera H; Sevelda P; Genger H; Weghaupt K
Geburtshilfe Frauenheilkd; 1985 Dec; 45(12):848-52. PubMed ID: 4085759
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing ovarian cancer survival after chemotherapy.
Webb MJ; Malkasian GD; Jorgensen EO
Obstet Gynecol; 1974 Oct; 44(4):564-70. PubMed ID: 4413425
[No Abstract] [Full Text] [Related]
6. The current therapeutic approaches to advanced ovarian cancer.
Nishimura H; Hamaguchi K; Miyahara K; Tazaki T; Tateno N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1691-6. PubMed ID: 2277209
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative radiotherapy of malignant ovarian tumors. I: Results following telecobalt grid irradiation].
Grimm D; Heider KM; Muth CP; Salewski D; Glaser FH; Hänsgen G; Kraft M
Radiobiol Radiother (Berl); 1982; 23(5):497-502. PubMed ID: 7156372
[No Abstract] [Full Text] [Related]
9. [Our experience in treating endometrioid ovarian carcinoma].
Angelova I; Slavchev B; Mushmov M
Akush Ginekol (Sofiia); 1991; 30(1):29-32. PubMed ID: 1724355
[TBL] [Abstract][Full Text] [Related]
10. The management of ovarian carcinoma--a review of 420 cases.
Barr W; Cowell AC; Chatfield WR
Scott Med J; 1970 Jul; 15(7):250-6. PubMed ID: 5427786
[No Abstract] [Full Text] [Related]
11. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
12. [Postoperative therapy of malignant ovarian tumors. II: Application of the large field technic].
Grimm D; Heider KM; Salewski D; Glaser FH; Hänsgen G; Kraft M; Schuchardt V
Radiobiol Radiother (Berl); 1982; 23(5):503-9. PubMed ID: 7156373
[No Abstract] [Full Text] [Related]
13. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
14. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
15. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
[TBL] [Abstract][Full Text] [Related]
16. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
[TBL] [Abstract][Full Text] [Related]
17. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
[TBL] [Abstract][Full Text] [Related]
18. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
Dzhilavian GA; Vinokurov VL
Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of postoperative radiotherapy by the moving strip technique for malignant ovarian tumor].
Fujiwara A; Mitao M; Nagai N; Matsumoto K; Katsube Y
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):873-81. PubMed ID: 6875342
[TBL] [Abstract][Full Text] [Related]
20. Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma.
Hoskins WJ; Lichter AS; Whittington R; Artman LE; Bibro MC; Park RC
Gynecol Oncol; 1985 Mar; 20(3):271-80. PubMed ID: 3972290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
